Nelfinavir indications and usage: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Indications and Usage== VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.<ref name="dailymed.nlm.nih.gov">{{Cite w...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Nelfinavir}} | |||
{{CMG}}; {{AE}} {{MM}} | |||
==Indications and Usage== | ==Indications and Usage== | ||
Latest revision as of 16:07, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Indications and Usage
VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.[1]
References
- ↑ "VIRACEPT (NELFINAVIR MESYLATE) TABLET, FILM COATED VIRACEPT (NELFINAVIR MESYLATE) POWDER [AGOURON PHARMACEUTICALS INC]". Text " accessdate" ignored (help)
Adapted from the FDA Package Insert.